Anbio Biotechnology (NASDAQ:NNNN) shares, rose in value on Wednesday, June 18, with the stock price up by 16.18% to the previous day’s close as strong demand from buyers drove the stock to $11.56.
Actively observing the price movement in the last trading, the stock closed the session at $9.95. The PE ratio was 190.76 over 12-month period. Referring to stock’s 52-week performance, its high was $9.99, and the low was $5.18. On the whole, NNNN has fluctuated by 53.32% over the past month.
With the market capitalization of Anbio Biotechnology currently standing at about $1.66 billion, investors are eagerly awaiting this quarter’s results, scheduled for in July.
The stock’s technical analysis shows that the price of NNNN currently trading nearly 36.45% and 56.32% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 89.00, while the 7-day volatility ratio is showing 7.20% which for the 30-day chart, stands at 4.13%. Furthermore, Anbio Biotechnology (NNNN)’s average true range (ATR) is 0.69.
Data on historical trading for Anbio Biotechnology (NASDAQ:NNNN) indicates that the trading volumes over the past 3 months, they’ve averaged 58.90K. According to company’s latest data on outstanding shares, there are 42.29 million shares outstanding.
Nearly 9.57% of Anbio Biotechnology’s shares belong to company insiders and institutional investors own 0.15% of the company’s shares. The stock has risen by 100.35% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the NNNN stock heading into the next quarter.
